{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:20:39Z","timestamp":1790130039836,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"crossref","award":["2017\/19019-4"],"award-info":[{"award-number":["2017\/19019-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-024-02422-2","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T10:05:50Z","timestamp":1719396350000},"page":"91-98","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Vitamin D supplementation in primary hyperparathyroidism: effects on 1,25(OH)2 vitamin D and FGF23 levels"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7616-2837","authenticated-orcid":false,"given":"S. G.","family":"Pallone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4900-7185","authenticated-orcid":false,"given":"M. N.","family":"Ohe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6590-6319","authenticated-orcid":false,"given":"L. M.","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4307-9663","authenticated-orcid":false,"given":"I. O.","family":"Nacaguma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. S.","family":"Kunii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0156-6746","authenticated-orcid":false,"given":"R. E. C.","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2669-4245","authenticated-orcid":false,"given":"S. S.","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5382-567X","authenticated-orcid":false,"given":"C. M. A.","family":"Brand\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7121-4458","authenticated-orcid":false,"given":"J. G. H.","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9186-2834","authenticated-orcid":false,"given":"M.","family":"Lazaretti-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,26]]},"reference":[{"key":"2422_CR1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00268-005-0239-y","volume":"30","author":"N \u00d6zbey","year":"2006","unstructured":"\u00d6zbey N et al (2006) Correlations between vitamin D status and biochemical\/clinical and pathological parameters in primary hyperparathyroidism. World J Surg 30:321\u2013326","journal-title":"World J Surg"},{"key":"2422_CR2","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.surg.2007.09.026","volume":"142","author":"BR Untch","year":"2007","unstructured":"Untch BR et al (2007) Impact of 25-hydroxyvitamin D deficiency on perioperative parathyroid hormone kinetics and results in patients with primary hyperparathyroidism. Surgery 142:1022\u20131026","journal-title":"Surgery"},{"key":"2422_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1136\/pgmj.2007.062653","volume":"84","author":"G Priya","year":"2008","unstructured":"Priya G et al (2008) Clinical and laboratory profile of primary hyperparathyroidism in India. Postgrad Med J 84:34\u201339","journal-title":"Postgrad Med J"},{"key":"2422_CR4","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1007\/s00268-009-0377-8","volume":"34","author":"BHH Lang","year":"2010","unstructured":"Lang BHH, Lo CY (2010) Vitamin D3 deficiency is associated with late-onset hypocalcemia after minimally invasive parathyroidectomy in a vitamin D borderline area. World J Surg 34:1350\u20131355","journal-title":"World J Surg"},{"key":"2422_CR5","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1210\/jc.2013-3978","volume":"99","author":"L Rolighed","year":"2014","unstructured":"Rolighed L et al (2014) Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial. J Clin Endocrinol Metab 99:1072\u20131080","journal-title":"J Clin Endocrinol Metab"},{"key":"2422_CR6","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1002\/jbmr.4682","volume":"37","author":"JP Bilezikian","year":"2022","unstructured":"Bilezikian JP et al (2022) Management of Primary Hyperparathyroidism. J Bone Miner Res 37:2391\u20132403","journal-title":"J Bone Miner Res"},{"key":"2422_CR7","doi-asserted-by":"publisher","first-page":"e10415","DOI":"10.1002\/jbm4.10415","volume":"4","author":"UM Kabadi","year":"2020","unstructured":"Kabadi UM (2020) Low 25-Hydroxyvitamin D in primary hyperparathyroidism: enhanced conversion into 1,25-hydroxyvitamin D may not be \u2018true\u2019 deficiency. JBMR plus 4:e10415","journal-title":"JBMR plus"},{"key":"2422_CR8","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1007\/s40618-020-01473-5","volume":"44","author":"A Song","year":"2021","unstructured":"Song A et al (2021) Safety and efficacy of common vitamin D supplementation in primary hyperparathyroidism and coexistent vitamin D deficiency and insufficiency: a systematic review and meta-analysis. J Endocrinol Invest 44:1667\u20131677","journal-title":"J Endocrinol Invest"},{"key":"2422_CR9","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"Holick MF et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96:1911\u20131930","journal-title":"J Clin Endocrinol Metab"},{"key":"2422_CR10","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"T Shimada","year":"2004","unstructured":"Shimada T et al (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19:429\u2013435","journal-title":"J Bone Miner Res"},{"key":"2422_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0140-6736(75)92736-1","volume":"2","author":"RJ Walton","year":"1975","unstructured":"Walton RJ, Bijvoet OLM (1975) Nomogram for derivation of renal threshold phosphate concentration. Lancet (London, England) 2:309\u2013310","journal-title":"Lancet (London, England)"},{"key":"2422_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000486060","volume":"50","author":"D Goltzman","year":"2018","unstructured":"Goltzman D, Mannstadt M, Marcocci C (2018) Physiology of the calcium-parathyroid hormone-vitamin D axis. Front Horm Res 50:1\u201313","journal-title":"Front Horm Res"},{"key":"2422_CR13","doi-asserted-by":"publisher","first-page":"826","DOI":"10.4065\/78.7.826","volume":"78","author":"RJ Singh","year":"2003","unstructured":"Singh RJ, Kumar R (2003) Fibroblast growth factor 23 concentrations in humoral hypercalcemia of malignancy and hyperparathyroidism. Mayo Clin Proc 78:826\u2013829","journal-title":"Mayo Clin Proc"},{"key":"2422_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1530\/eje.0.1510055","volume":"151","author":"H Yamashita","year":"2004","unstructured":"Yamashita H et al (2004) Fibroblast growth factor (FGF)-23 in patients with primary hyperparathyroidism. Eur J Endocrinol 151:55\u201360","journal-title":"Eur J Endocrinol"},{"key":"2422_CR15","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.4065\/79.12.1508","volume":"79","author":"PJ Tebben","year":"2004","unstructured":"Tebben PJ, Singh RJ, Clarke BL, Kumar R (2004) Fibroblast growth factor 23, parathyroid hormone, and 1alpha,25-dihydroxyvitamin D in surgically treated primary hyperparathyroidism. Mayo Clin Proc 79:1508\u20131513","journal-title":"Mayo Clin Proc"},{"key":"2422_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1530\/EJE-11-0523","volume":"166","author":"JE Witteveen","year":"2012","unstructured":"Witteveen JE, Van Lierop AH, Papapoulos SE, Hamdy NAT (2012) Increased circulating levels of FGF23: an adaptive response in primary hyperparathyroidism? Eur J Endocrinol 166:55\u201360","journal-title":"Eur J Endocrinol"},{"key":"2422_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1530\/eje.1.02053","volume":"154","author":"K Kobayashi","year":"2006","unstructured":"Kobayashi K et al (2006) Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism. Eur J Endocrinol 154:93\u201399","journal-title":"Eur J Endocrinol"},{"key":"2422_CR18","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1210\/en.2019-00017","volume":"160","author":"Y Nagata","year":"2019","unstructured":"Nagata Y et al (2019) Attenuated dentin matrix protein 1 enhances fibroblast growth factor 23 in calvaria in a primary hyperparathyroidism model. Endocrinology 160:1348\u20131358","journal-title":"Endocrinology"},{"key":"2422_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/jendso\/bvac027","volume":"6","author":"Y Nagata","year":"2022","unstructured":"Nagata Y et al (2022) Parathyroid hormone regulates circulating levels of sclerostin and FGF23 in a primary hyperparathyroidism model. J Endocr Soc 6:1\u201310","journal-title":"J Endocr Soc"},{"key":"2422_CR20","doi-asserted-by":"publisher","first-page":"E1830","DOI":"10.1210\/jc.2014-1308","volume":"99","author":"H Alshayeb","year":"2014","unstructured":"Alshayeb H et al (2014) Activation of FGF-23 mediated vitamin D degradative pathways by cholecalciferol. J Clin Endocrinol Metab 99:E1830\u2013E1837","journal-title":"J Clin Endocrinol Metab"},{"key":"2422_CR21","doi-asserted-by":"publisher","first-page":"e102965","DOI":"10.1371\/journal.pone.0102965","volume":"9","author":"B Nygaard","year":"2014","unstructured":"Nygaard B et al (2014) Effects of high doses of cholecalciferol in normal subjects: a randomized double-blinded, placebo-controlled trial. PLoS One 9:e102965","journal-title":"PLoS One"},{"key":"2422_CR22","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s40618-017-0739-2","volume":"41","author":"T Kamelian","year":"2018","unstructured":"Kamelian T, Saki F, Jeddi M, Dabbaghmanesh MH, Omrani GHR (2018) Effect of Cholecalciferol therapy on serum FGF23 in vitamin D deficient patients: a randomized clinical trial. J Endocrinol Invest 41:299\u2013306","journal-title":"J Endocrinol Invest"},{"key":"2422_CR23","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1007\/s00198-019-05102-7","volume":"30","author":"N Charoenngam","year":"2019","unstructured":"Charoenngam N, Rujirachun P, Holick MF, Ungprasert P (2019) Oral vitamin D3 supplementation increases serum fibroblast growth factor 23 concentration in vitamin D-deficient patients: a systematic review and meta-analysis. Osteoporos Int 30:2183\u20132193","journal-title":"Osteoporos Int"},{"key":"2422_CR24","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/s41430-020-00725-0","volume":"75","author":"A Zittermann","year":"2021","unstructured":"Zittermann A, Berthold HK, Pilz S (2021) The effect of vitamin D on fibroblast growth factor 23: a systematic review and meta-analysis of randomized controlled trials. Eur J Clin Nutr 75:980\u2013987","journal-title":"Eur J Clin Nutr"},{"key":"2422_CR25","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1093\/ejendo\/lvad131","volume":"189","author":"DMA Ratsma","year":"2023","unstructured":"Ratsma DMA, Muller M, Koedam M, Zillikens MC, van der Eerden BCJ (2023) In vitro regulation of fibroblast growth factor 23 by 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D synthesized by osteocyte-like MC3T3-E1 cells. Eur J Endocrinol 189:448\u2013459","journal-title":"Eur J Endocrinol"},{"key":"2422_CR26","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3390\/nu10060659","volume":"10","author":"S De Niet","year":"2018","unstructured":"De Niet S et al (2018) A randomized study to compare a monthly to a daily administration of vitamin D3 supplementation. Nutrients 10:659","journal-title":"Nutrients"},{"key":"2422_CR27","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1373\/clinchem.2015.244913","volume":"61","author":"A Zittermann","year":"2015","unstructured":"Zittermann A, Ernst JB, Birschmann I, Dittrich M (2015) Effect of vitamin D or activated vitamin D on circulating 1,25-dihydroxyvitamin D concentrations: a systematic review and metaanalysis of randomized controlled trials. Clin Chem 61:1484\u20131494","journal-title":"Clin Chem"},{"key":"2422_CR28","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3390\/nu9060623","volume":"9","author":"C Trummer","year":"2017","unstructured":"Trummer C et al (2017) Effects of vitamin D supplementation on IGF-1 and calcitriol: a randomized-controlled trial. Nutrients 9:623","journal-title":"Nutrients"},{"key":"2422_CR29","doi-asserted-by":"publisher","first-page":"109095","DOI":"10.1016\/j.steroids.2022.109095","volume":"187","author":"GG Okai","year":"2022","unstructured":"Okai GG et al (2022) LC-MS\/MS reduces interference by high levels of 25(OH)D and its metabolites on measured 1,25(OH)2D. Steroids 187:109095","journal-title":"Steroids"},{"key":"2422_CR30","doi-asserted-by":"publisher","first-page":"5831","DOI":"10.1210\/jc.2019-00207","volume":"104","author":"AR Martineau","year":"2019","unstructured":"Martineau AR et al (2019) Differential effects of oral boluses of vitamin D2 vs vitamin D3 on vitamin D metabolism: a randomized controlled trial. J Clin Endocrinol Metab 104:5831\u20135839","journal-title":"J Clin Endocrinol Metab"},{"key":"2422_CR31","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1210\/jc.2012-2114","volume":"98","author":"RM Biancuzzo","year":"2013","unstructured":"Biancuzzo RM, Clarke N, Reitz RE, Travison TG, Holick MF (2013) Serum concentrations of 1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 in response to vitamin D2 and vitamin D3 supplementation. J Clin Endocrinol Metab 98:973\u2013979","journal-title":"J Clin Endocrinol Metab"},{"key":"2422_CR32","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s12020-018-1659-4","volume":"62","author":"LS Bislev","year":"2018","unstructured":"Bislev LS et al (2018) The effect of vitamin D3 supplementation on markers of cardiovascular health in hyperparathyroid, vitamin D insufficient women: a randomized placebo-controlled trial. Endocrine 62:182\u2013194","journal-title":"Endocrine"},{"key":"2422_CR33","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.2215\/CJN.03130314","volume":"9","author":"JR Stubbs","year":"2014","unstructured":"Stubbs JR, Zhang S, Friedman PA, Nolin TD (2014) Decreased conversion of 25-hydroxyvitamin D3 to 24,25-dihydroxyvitamin D3 following cholecalciferol therapy in patients with CKD. Clin J Am Soc Nephrol 9:1965\u20131973","journal-title":"Clin J Am Soc Nephrol"},{"key":"2422_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4158\/EP161476.OR","volume":"23","author":"E Castellano","year":"2017","unstructured":"Castellano E et al (2017) Nephrolithiasis in primary hyperparathyroidism: a comparison between silent and symptomatic patients. Endocr Pract 23:157\u2013162","journal-title":"Endocr Pract"},{"key":"2422_CR35","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s12020-009-9211-1","volume":"36","author":"ML Isidro","year":"2009","unstructured":"Isidro ML, Ruano B (2009) Biochemical effects of calcifediol supplementation in mild, asymptomatic, hyperparathyroidism with concomitant vitamin D deficiency. Endocrine 36:305\u2013310","journal-title":"Endocrine"},{"key":"2422_CR36","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/BF03345354","volume":"28","author":"S Corbetta","year":"2005","unstructured":"Corbetta S et al (2005) Risk factors associated to kidney stones in primary hyperparathyroidism. J Endocrinol Invest 28:122\u2013128","journal-title":"J Endocrinol Invest"},{"key":"2422_CR37","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.beem.2018.09.001","volume":"32","author":"S Minisola","year":"2018","unstructured":"Minisola S, Gianotti L, Bhadada S, Silverberg SJ (2018) Classical complications of primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab 32:791\u2013803","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2422_CR38","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/cen.12398","volume":"80","author":"VN Shah","year":"2014","unstructured":"Shah VN, Shah CS, Bhadada SK, Sudhakar Rao D (2014) Effect of 25 (OH) D replacements in patients with primary hyperparathyroidism (PHPT) and coexistent vitamin D deficiency on serum 25(OH) D, calcium and PTH levels: a meta-analysis and review of literature. Clin Endocrinol (Oxf) 80:797\u2013803","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02422-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-024-02422-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02422-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T12:55:38Z","timestamp":1736772938000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-024-02422-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,26]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["2422"],"URL":"https:\/\/doi.org\/10.1007\/s40618-024-02422-2","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,26]]},"assertion":[{"value":"16 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Ethics and Research Committee of the Federal University of S\u00e3o Paulo (registration number 89044117.9.0000.5505).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"All participants signed an Informed Consent Form.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}